| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P T Ninan, J Berge. Symptomatic and syndromal anxiety and depression. Depression and anxiety. vol 14. issue 2. 2001-12-05. PMID:11668660. |
the literature on treatment response documents that selective serotonin reuptake inhibitors are effective in the treatment of the various anxiety disorders, including when comorbid major depression is present. |
2001-12-05 |
2023-08-12 |
Not clear |
| P T Ninan, J Berge. Symptomatic and syndromal anxiety and depression. Depression and anxiety. vol 14. issue 2. 2001-12-05. PMID:11668660. |
the literature also suggests that tricyclic antidepressant medications have superior benefits over selective serotonin reuptake inhibitors in major depression. |
2001-12-05 |
2023-08-12 |
Not clear |
| A W Poret, C Neslusan, J F Ricci, S Wang, Z M Khan, J W Kwon. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. vol 4. issue 5. 2001-12-05. PMID:11705126. |
the objective of this study was to evaluate the health care costs associated with the treatment of a new episode of depression with bupropion sustained release (sr) rather than with other antidepressants (selective serotonin reuptake inhibitors [ssris], tricyclic antidepressants [tcas], and serotonin norepinephrine reuptake inhibitors [snris]). |
2001-12-05 |
2023-08-12 |
Not clear |
| G Zalsman, A Frisch, M Bromberg, J Gelernter, E Michaelovsky, A Campino, Z Erlich, S Tyano, A Apter, A Weizma. Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits. American journal of medical genetics. vol 105. issue 3. 2001-12-04. PMID:11353442. |
the serotonin transporter-linked promoter region polymorphism (5-httlpr) is thought to be associated with some serotonin dysfunction-related psychopathologies such as depression and anxiety disorders. |
2001-12-04 |
2023-08-12 |
Not clear |
| J Q Bostic, J Prince, K Brown, S Plac. A retrospective study of citalopram in adolescents with depression. Journal of child and adolescent psychopharmacology. vol 11. issue 2. 2001-12-04. PMID:11436955. |
recent evidence suggests that the selective serotonin reuptake inhibitors are safe and efficacious in treating juveniles with depression. |
2001-12-04 |
2023-08-12 |
Not clear |
| A Zangen, R Nakash, D H Overstreet, G Yadi. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology. vol 155. issue 4. 2001-12-04. PMID:11441434. |
current hypotheses on the etiology of depression attribute the disorder to alterations in serotonin and norepinephrine neurotransmission. |
2001-12-04 |
2023-08-12 |
Not clear |
| G P Sholeva. Family therapy for conduct disorders. Child and adolescent psychiatric clinics of North America. vol 10. issue 3. 2001-12-04. PMID:11449809. |
the role of neurotransmitters (such as serotonin) in the production of irritability, provocativeness, coercive family processes, and subsequent depression in the caregiver or the child. |
2001-12-04 |
2023-08-12 |
human |
| G Dell'Agnello, R Ceravolo, A Nuti, G Bellini, A Piccinni, C D'Avino, L Dell'Osso, U Bonuccell. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clinical neuropharmacology. vol 24. issue 4. 2001-12-04. PMID:11479393. |
selective serotonin reuptake inhibitors (ssris) have been reported to be useful in the treatment of depression in patients with parkinson's disease (pd). |
2001-12-04 |
2023-08-12 |
Not clear |
| C G Okiishi, S Paradiso, R G Robinso. Gender differences in depression associated with neurologic illness: clinical correlates and pharmacologic response. The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia. vol 4. issue 2. 2001-12-04. PMID:11480103. |
although gender-based outcome data on the treatment of functional depression reveal better tolerability and response to serotonin reuptake inhibitors in women than in men, this phenomenon cannot be generalized to depression in neurologic disease. |
2001-12-04 |
2023-08-12 |
Not clear |
| F Cayetanot, L Bodineau, A Frugièr. 5-HT acting on 5-HT(1/2) receptors does not participate in the in vitro hypoxic respiratory depression. Neuroscience research. vol 41. issue 1. 2001-12-04. PMID:11535296. |
5-ht acting on 5-ht(1/2) receptors does not participate in the in vitro hypoxic respiratory depression. |
2001-12-04 |
2023-08-12 |
rat |
| K W Raines, F J Seidler, T A Slotki. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Brain research. Developmental brain research. vol 130. issue 1. 2001-12-04. PMID:11557094. |
because the cpf effects involve 5ht, a neurotransmitter intimately involved in the control of mood, we suggest the need to evaluate behaviors that typify animal models of depression. |
2001-12-04 |
2023-08-12 |
rat |
| P Blie. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. Journal of psychiatry & neuroscience : JPN. vol 26 Suppl. 2001-12-04. PMID:11590967. |
in addition, interactions between ne neurons and 5-ht neurons have implications for the treatment of depression and anxiety disorders. |
2001-12-04 |
2023-08-12 |
Not clear |
| W H Sauer, J A Berlin, S E Kimme. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. vol 104. issue 16. 2001-12-04. PMID:11602490. |
selective serotonin reuptake inhibitors (ssris) may reduce this risk through attenuation of serotonin-mediated platelet activation in addition to treatment of depression itself. |
2001-12-04 |
2023-08-12 |
Not clear |
| M Mokhtarani, A N Mahgoub, N Morioka, A G Doufas, M Dae, T E Shaughnessy, A R Bjorksten, D I Sessle. Buspirone and meperidine synergistically reduce the shivering threshold. Anesthesia and analgesia. vol 93. issue 5. 2001-12-04. PMID:11682404. |
we tested the hypothesis that the combination of buspirone (a serotonin 1a partial agonist) and meperidine synergistically reduces the shivering threshold (triggering tympanic membrane temperature) to at least 34 degrees c while producing little sedation or respiratory depression. |
2001-12-04 |
2023-08-12 |
human |
| L K Solai, B H Mulsant, B G Polloc. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs & aging. vol 18. issue 5. 2001-11-01. PMID:11392444. |
selective serotonin reuptake inhibitors for late-life depression: a comparative review. |
2001-11-01 |
2023-08-12 |
Not clear |
| L K Solai, B H Mulsant, B G Polloc. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs & aging. vol 18. issue 5. 2001-11-01. PMID:11392444. |
selective serotonin (5-hydroxytryptamine: 5-ht) reuptake inhibitors (ssris), the most commonly prescribed antidepressants, are usually used as first-line agents for elderly patients with depression. |
2001-11-01 |
2023-08-12 |
Not clear |
| b' E G\\xc3\\xb3mez, R Catal\\xc3\\xa1n, R Navin\\xc3\\xa9s, C Gast\\xc3\\xb. [Serotonin receptor changes in depression: evidences and limitations]. Actas espanolas de psiquiatria. vol 29. issue 3. 2001-11-01. PMID:11412493.' |
serotonin and serotonin receptors might be involved in the pathophysiology of depression. |
2001-11-01 |
2023-08-12 |
Not clear |
| E Mundo, G Zai, L Lee, S V Parikh, J L Kenned. The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 25. issue 4. 2001-11-01. PMID:11557174. |
the serotonin (5ht) receptor genes are considered good candidates for major depression (md), bipolar disorder (bp), and obsessive-compulsive disorder (ocd). |
2001-11-01 |
2023-08-12 |
Not clear |
| M Honda, H On. No involvement of 5-HT(7) or 5-HT(1D) receptors in the (R)-8-OH-DPAT-induced depression of the monosynaptic reflex in spinalized rats. European journal of pharmacology. vol 427. issue 2. 2001-11-01. PMID:11557264. |
no involvement of 5-ht(7) or 5-ht(1d) receptors in the (r)-8-oh-dpat-induced depression of the monosynaptic reflex in spinalized rats. |
2001-11-01 |
2023-08-12 |
rat |
| M Honda, H On. No involvement of 5-HT(7) or 5-HT(1D) receptors in the (R)-8-OH-DPAT-induced depression of the monosynaptic reflex in spinalized rats. European journal of pharmacology. vol 427. issue 2. 2001-11-01. PMID:11557264. |
pretreatment with 2a-(4-phenyl-1,2,3,6-tetrahydropyridal)butyl)-2a,3,4,5-tetrahydrobenzo[c,d]indol-2(1h)-one (dr4004) and (r)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrolidine (sb-269970), new selective 5-ht(7) receptors antagonists, and n-[methoxy-3-(4-methyl-l-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide (gr127935), a selective 5-ht(1d) receptor antagonist, had no effect on (r)-8-oh-dpat-induced depression. |
2001-11-01 |
2023-08-12 |
rat |